Clinical Trials in New York

Showing 2121-2140 of 19,464 trials

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

NCT07227636

The researchers are doing this study to find out whether the combination of botensilimab and balstilimab (BOT/BAL), followed by balstilimab alone, is an effective treatment for people with microsatellite stable (MSS) colorectal cancer or colorectal liver metastases (CRLM) who have measurable residual disease (MRD) after standard treatment with surgery and chemotherapy or total neoadjuvant therapy (TNT).

Colorectal CancerRectal Cancer

Memorial Sloan Kettering Cancer Center284 participantsStarted Nov 2025

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +4 more locations

Active Not RecruitingPhase 2< 1 mile

Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)

NCT04375228

The purpose of this study is to examine how effective rituximab or tocilizumab are in treating side effects for people who are receiving immunotherapy treatment requiring prolonged steroid use. Immune-related side effects are caused by the activation of the immune system. Because rituximab and tocilizumab have been shown to effectively in treating other diseased that involve immune system activation, this study seeks to evaluate how effective they will be in treating immune-related side effects in people receiving immunotherapy treatment for cancer.

Columbia University8 participantsStarted Sep 2020

Baltimore, Maryland, United States • New York, New York, United States • New York, New York, United States

A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs)

Find Trials by Condition in New York

Vincristine Pharmacokinetics in Infants

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

Split Chest Breast Neurotization

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

CLOZAPINE Response in Biotype-1

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1